VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: SK Hynix Plunges 10% in Asian Tech Selloff
Value Add VC/Pulse/IPOBRIEF

SK Hynix Plunges 10% in Asian Tech Selloff

SK Hynix fell nearly 10% and Samsung dropped over 6% as Asian tech stocks tracked a Wall Street AI-name selloff, the second sharp chip-sector drop in the Korean chipmaker's shares in two weeks.

By the Numbers

-9.71%
SK Hynix
-6.13%
Samsung Electronics
-8.84%
Kioxia
-4.36%
SoftBank Group
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
August 6, 2026
1 min read
ShareXLinkedInEmail
TC

The VC Read · Trace's Take

Trace Cohen

Two sharp SK Hynix drops inside two weeks, both tracking Wall Street rather than any change in Asian chip demand, means the stock is trading almost entirely as a leveraged proxy for US AI sentiment right now. If you're underwriting memory-chip exposure as a hedge against US AI-stock concentration, this selloff is the data point that says the correlation is currently too tight for that hedge to actually work.

Analysis

Asian technology stocks fell sharply on Thursday, led by SK Hynix, which dropped 9.71%, and Samsung Electronics, down 6.13%, as the region's chipmakers tracked an overnight pullback in US AI-linked names, according to CNBC. Japanese memory maker Kioxia fell 8.84%, chip equipment maker Tokyo Electron dropped more than 5%, SoftBank Group fell 4.36%, and Taiwan's TSMC was down 1.46%.

Pulse has previously covered SK Hynix's Nasdaq listing as one of the more closely watched Asian tech IPOs of the year, and its stock has become something of a bellwether for global AI sentiment given how directly its earnings are tied to memory-chip demand from AI data centers. This is the second sharp chip-sector drop tied to SK Hynix in roughly a week -- the stock also fell after a disappointing earnings report on July 29 that dragged down chip names globally.

The pattern across both selloffs is the same: memory and AI-chip stocks in Asia are now trading with tight, near-immediate correlation to overnight US tech moves, a level of coupling that gives South Korean and Japanese chipmakers very little room to trade on their own fundamentals when Wall Street's AI trade wobbles, regardless of whether the underlying demand picture in Asia has actually changed.

ShareXLinkedInEmail

More on

Samsung →SK Hynix →

Reported by CNBC · First reported by CNBC · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 9, 2026

What BofA's Extreme Bull Signal Means for Your Marks

Illustration for: What BofA's Extreme Bull Signal Means for Your Marks
IPO

What BofA's Extreme Bull Signal Means for Your Marks

BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.

IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com